Show simple item record

dc.contributor.authorGrigore, Alexandru Dan
Ben-Jacob, Eshel
Farach-Carson, Mary C.
dc.date.accessioned 2016-03-24T18:24:35Z
dc.date.available 2016-03-24T18:24:35Z
dc.date.issued 2015
dc.identifier.citation Grigore, Alexandru Dan, Ben-Jacob, Eshel and Farach-Carson, Mary C.. "Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?." Frontiers in Oncology, 5, (2015) Frontiers Media S.A.: http://dx.doi.org/10.3389/fonc.2015.00037.
dc.identifier.urihttps://hdl.handle.net/1911/88646
dc.description.abstract Neuroendocrine differentiation (NED) marks a structural and functional feature of certain cancers, including prostate cancer (PCa), whereby the malignant tissue contains a significant proportion of cells displaying neuronal, endocrine, or mixed features. NED cells produce, and can secrete, a cocktail of mediators commonly encountered in the nervous system, which may stimulate and coordinate cancer growth. In PCa, NED appears during advanced stages, subsequent to treatment, and accompanies treatment resistance and poor prognosis. However, the term "neuroendocrine" in this context is intrinsically vague. This article seeks to provide a framework on which a unified view of NED might emerge. First, we review the mutually beneficial interplay between PCa and neural structures, mainly supported by cell biology experiments and neurological conditions. Next, we address the correlations between PCa and neural functions, as described in the literature. Based upon the integration of clinical and basic observations, we suggest that it is legitimate to seek for true neural differentiation, or neuromimicry, in cancer progression, most notably in PCa cells exhibiting what is commonly described as NED.
dc.language.iso eng
dc.publisher Frontiers Media S.A.
dc.rights This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.title Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?
dc.type Journal article
dc.contributor.funder National Institutes of Health/National Cancer Institute
dc.citation.journalTitle Frontiers in Oncology
dc.contributor.org Center for Theoretical Biological Physics
dc.subject.keywordchromogranin A
interleukin-6
neural differentiation
neuroendocrine differentiation
prostate cancer
dc.citation.volumeNumber 5
dc.type.dcmi Text
dc.identifier.doihttp://dx.doi.org/10.3389/fonc.2015.00037
dc.identifier.pmcid PMC4347593
dc.identifier.pmid 25785244
dc.identifier.grantID PO1CA98912 (National Institutes of Health/National Cancer Institute)
dc.type.publication publisher version


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record